Invo Fertility Inc Reports Results For The Quarter Ended March 31: Earnings Summary

INVO Fertility

22/06/2026 21:54

INVO Fertility Inc IVF.OQ reported a quarterly adjusted loss of $3.38​​ per share for the quarter ended March 31.  The lone analyst forecast for the quarter was for a loss of $1.25 per share. 
Revenue rose 24.3% to $2.02 million from a year ago; analysts expected $1.98 million. 
INVO Fertility Inc's reported EPS for the quarter was a loss of $3.38​.
The company reported a quarterly loss of $5.54 million.
INVO Fertility Inc shares had fallen by 44.9% this quarter and lost 60.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for INVO Fertility Inc is $20.00, about 92.5% above its last closing price of $1.50
This summary was machine generated from LSEG data June 22 at 08:54 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Mar. 31 2026 
-1.25
-3.38
Missed
Dec. 31 2025 
-2.75
-1.97 hundred
Missed